001     144762
005     20240229112636.0
024 7 _ |a 10.1158/1055-9965.EPI-19-0313
|2 doi
024 7 _ |a pmid:31481495
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:65831161
|2 altmetric
037 _ _ |a DKFZ-2019-02194
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Butt, Julia Anna
|0 P:(DE-He78)31d7c3e829be03400641f80b821ef728
|b 0
|e First author
|u dkfz
245 _ _ |a Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.
260 _ _ |a Philadelphia, Pa.
|c 2019
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1600673487_10088
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:F022#
520 _ _ |a There is a lack of prospective data on the potential association of Fusobacterium nucleatum (F. nucleatum) and colorectal cancer risk. In this study, we assessed whether antibody responses to F. nucleatum are associated with colorectal cancer risk in prediagnostic serum samples in the European Prospective Investigation into Nutrition and Cancer (EPIC) cohort.We applied a multiplex serology assay to simultaneously measure antibody responses to 11 F. nucleatum antigens in prediagnostic serum samples from 485 colorectal cancer cases and 485 matched controls. Conditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CI).We observed neither a statistically significant colorectal cancer risk association for antibodies to individual F. nucleatum proteins nor for combined positivity to any of the 11 proteins (OR, 0.81; 95% CI, 0.62-1.06).Antibody responses to F. nucleatum proteins in prediagnostic serum samples from a subset of colorectal cancer cases and matched controls within the EPIC study were not associated with colorectal cancer risk.Our findings in prospectively ascertained serum samples contradict the existing literature on the association of F. nucleatum with colorectal cancer risk. Future prospective studies, specifically detecting F. nucleatum in stool or tissue biopsies, are needed to complement our findings.
536 _ _ |a 316 - Infections and cancer (POF3-316)
|0 G:(DE-HGF)POF3-316
|c POF3-316
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Jenab, Mazda
|b 1
700 1 _ |a Pawlita, Michael
|0 P:(DE-He78)d99bad949ba3ae93859eedae5ac266da
|b 2
|u dkfz
700 1 _ |a Overvad, Kim
|b 3
700 1 _ |a Tjonneland, Anne
|0 0000-0003-4385-2097
|b 4
700 1 _ |a Olsen, Anja
|b 5
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 6
700 1 _ |a Carbonnel, Franck
|b 7
700 1 _ |a Mancini, Francesca Romana
|0 0000-0003-2297-3869
|b 8
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 9
|u dkfz
700 1 _ |a Kühn, Tilman
|0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
|b 10
|u dkfz
700 1 _ |a Boeing, Heiner
|b 11
700 1 _ |a Trichopoulou, Antonia
|b 12
700 1 _ |a Karakatsani, Anna
|0 0000-0002-3275-2026
|b 13
700 1 _ |a Palli, Domenico
|0 0000-0002-5558-2437
|b 14
700 1 _ |a Pala, Valeria Maria
|0 0000-0001-5438-970X
|b 15
700 1 _ |a Tumino, Rosario
|0 0000-0003-2666-414X
|b 16
700 1 _ |a Sacerdote, Carlotta
|b 17
700 1 _ |a Panico, Salvatore
|b 18
700 1 _ |a Bueno-de-Mesquita, Bas
|b 19
700 1 _ |a van Gils, Carla H
|b 20
700 1 _ |a Vermeulen, Roel C H
|b 21
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 22
700 1 _ |a Quirós, José Ramón
|b 23
700 1 _ |a Duell, Eric Jeffrey
|0 0000-0001-5256-0163
|b 24
700 1 _ |a Sánchez, Maria-Jose
|0 0000-0003-4817-0757
|b 25
700 1 _ |a Dorronsoro, Miren
|b 26
700 1 _ |a Huerta, José María
|0 0000-0002-9637-3869
|b 27
700 1 _ |a Ardanaz, Eva
|0 0000-0001-8434-2013
|b 28
700 1 _ |a Van Guelpen, Bethany
|0 0000-0002-9692-101X
|b 29
700 1 _ |a Harlid, Sophia
|0 0000-0001-8540-6891
|b 30
700 1 _ |a Perez-Cornago, Aurora
|0 0000-0002-5652-356X
|b 31
700 1 _ |a Gunter, Marc J
|b 32
700 1 _ |a Murphy, Neil
|b 33
700 1 _ |a Freisling, Heinz
|0 0000-0001-8648-4998
|b 34
700 1 _ |a Aune, Dagfinn
|b 35
700 1 _ |a Waterboer, Tim
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 36
|e Last author
|u dkfz
700 1 _ |a Hughes, David J
|0 0000-0003-1668-8770
|b 37
773 _ _ |a 10.1158/1055-9965.EPI-19-0313
|g Vol. 28, no. 9, p. 1552 - 1555
|0 PERI:(DE-600)2036781-8
|n 9
|p 1552 - 1555
|t Cancer epidemiology, biomarkers & prevention
|v 28
|y 2019
|x 1538-7755
909 C O |p VDB
|o oai:inrepo02.dkfz.de:144762
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)31d7c3e829be03400641f80b821ef728
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)d99bad949ba3ae93859eedae5ac266da
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 36
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|2 G:(DE-HGF)POF3-300
|v Infections and cancer
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)F022-20160331
|k F022
|l F022 Infektionen und Krebs-Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l F020 Molekulare Diagnostik Oncogener Infektionen
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F022-20160331
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21